Epilepsia Open

Papers
(The H4-Index of Epilepsia Open is 25. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
A companion to the preclinical common data elements for proteomics, lipidomics, and metabolomics data in rodent epilepsy models. A report of the TASK3‐WG4 omics working group of the ILAE/AES joint tra91
Total posterior quadrant disconnection for drug‐resistant epilepsy in children83
An interview with Ifrah Zawar, 2023 Epilepsia Open prize winner for clinical research68
Epilepsy following neonatal encephalopathy—Future directions48
Building a dashboard to inform policy and clinical practice using the Irish epilepsy electronic patient record: Towards a learning health system40
Characterization of low‐grade epilepsy‐associated tumor from implanted stereoelectroencephalography electrodes39
Effectiveness of perampanel as the only add‐on: Retrospective, multicenter, observational real‐life study on epilepsy patients38
Risk of COVID‐19 infection and seizure exacerbation among patients with epilepsy during the peak of Omicron wave37
Incorporation bias in clinical prediction models for epilepsy35
Sudden unexpected death in epilepsy ( SUDEP ): Risk management of pediatric patients with epilepsy34
Alterations of apparent diffusion coefficient from ultra high b‐values in the bilateral thalamus and striatum in MRI‐negative drug‐resistant epilepsy32
A first in disease trial of the safety, tolerability, and anti‐seizure effects of ES ‐481 in drug‐resistant epilepsy30
One‐year seizure freedom and quality of life in patients with drug‐resistant epilepsy receiving adjunctive vagus nerve stimulation in Japan30
Key steps and barriers in the journey of patients with epilepsy through the National Healthcare System in Spain: The EPIPASS qualitative study29
Longitudinal hippocampal diffusion‐weighted imaging and T2 relaxometry demonstrate regional abnormalities which are stable and predict subfield pathology in temporal lobe epilepsy29
Intestinal microbiome alterations in pediatric epilepsy: Implications for seizures and therapeutic approaches28
Long‐term effectiveness and tolerability of ketogenic diet therapy in patients with genetic developmental and epileptic encephalopathy onset within the first 6 months of life28
Trends in antiseizure medication monotherapy for pediatric epilepsy in the United States28
Assessment of tau phosphorylation and β‐amyloid pathology in human drug‐resistant epilepsy28
Comparative efficacy and safety of stiripentol, cannabidiol and fenfluramine as first‐line add‐on therapies for seizures in Dravet syndrome: A network meta‐analysis27
Astrocyte subtype‐specific alterations in the dentate gyrus of individuals with mesial temporal lobe epilepsy26
Neonatal seizures: Advances in diagnosis and management25
Ex‐SPECTing success: Predictors of successful SPECT radiotracer injection during presurgical video‐EEG admissions25
Thank you to our reviewers of 202325
Efficacy and Safety of adjunctive Perampanel in a prospective, real‐world, Phase IV study in Indian patients aged ≥12 years for Treatment of focal‐onset Epilepsy: Study 50825
Exploring the impact of hippocampal sclerosis on white matter tracts and memory in individuals with mesial temporal lobe epilepsy25
Deficiency of nNOS in adult‐born dentate granule cells causes epilepsy25
0.20684695243835